Recently, clinical studies have demonstrated that PD-L1 is detected in exosomes purified from the plasma of patients (gastric, breast, pancreatic, oral-oesophageal cancers, HNSCC, NSCLC, and melanoma). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.